The board of Kaynes Technology has announced a floor price of ₹5,625.75 per share to raise ₹1,600 crore though issue of equities on a qualified institutional placement basis. The fundraise plan was approved by the company’s board on January 22 and by shareholders on February 14, the company said in regulatory filing. The QIP issue opened on Thursday.
According to market buzz, pivate equity firm TPG Asia is likely to divest a 6% stake in contract research and manufacturing company Sai Life Sciences Ltd through block deals.
Four promoter entities of Privi Speciality Chemicals - Bhaktavatsala Rao Doppalapudi, Vijaykumar Doppalapudi, Vinaykumar Doppalapudi Rao and Vivira Investment and Trading - has sold a combined 4.09 per cent stake in the company for ₹330 crore through open market transactions. They sold a total of 16 lakh shares in the price range of ₹2,055-2,087.70. After the transactions, the combined promoter holding in Privi Speciality Chemicals declined to 69.96 per cent from 74.05 per cent. SBI Mutual Fund and SBI Funds Management bought a little over 15.02 lakh shares, Privi Speciality Chemicals, at an average price of Rs 2,055.
Hong Kong-based SAIF Partners, through its arm SAIF Partners India IV, sold 53.98 lakh shares or a 1.38 per cent stake in Le Travenues Technology at an average price of ₹180.50. The London-based investment manager Schroders bought 53.68 lakh shares of the company that operates Ixigo. Following the share sale, SAIF Partners’ holding in Le Travenues Technology dipped to 12.64 per cent from 14.02 per cent.